Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
55.89
-1.93 (-3.34%)
At close: Jul 15, 2025, 4:00 PM
56.32
+0.43 (0.77%)
Pre-market: Jul 16, 2025, 5:55 AM EDT
Tempus AI Employees
Tempus AI had 2,400 employees as of December 31, 2024. The number of employees increased by 100 or 4.35% compared to the previous year.
Employees
2,400
Change (1Y)
100
Growth (1Y)
4.35%
Revenue / Employee
$334,715
Profits / Employee
-$300,546
Market Cap
9.68B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TEM News
- 5 days ago - Apple Acquisition Buzz: Its $60 Billion War Chest Is Enough To Buy Datadog And Tempus - Benzinga
- 6 days ago - Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients - Business Wire
- 7 days ago - Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer - Business Wire
- 14 days ago - Tempus AI: High-Growth And High-Risk - Seeking Alpha
- 15 days ago - Tempus Announces Pricing of Upsized Offering of $650 Million of Convertible Senior Notes - Business Wire
- 15 days ago - Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense - Business Wire
- 20 days ago - Ambry Genetics' CARE Program Validated for Accuracy in Identifying High-Risk Patients for Hereditary Cancer Testing - Business Wire
- 20 days ago - Tempus AI Is Well Worth Its Price Tag - Seeking Alpha